title: Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells.
abstract: The peptide hormone ghrelin is released from a distinct group of gastrointestinal cells in response to caloric restriction, whereas its levels fall after eating. The mechanisms by which ghrelin secretion is regulated remain largely unknown. Here, we have used primary cultures of mouse gastric mucosal cells to investigate ghrelin secretion, with an emphasis on the role of glucose. Ghrelin secretion from these cells upon exposure to different d-glucose concentrations, the glucose antimetabolite 2-deoxy-d-glucose, and other potential secretagogues was assessed. The expression profile of proteins involved in glucose transport, metabolism, and utilization within highly enriched pools of mouse ghrelin cells and within cultured ghrelinoma cells was also determined. Ghrelin release negatively correlated with d-glucose concentration. Insulin blocked ghrelin release, but only in a low d-glucose environment. 2-Deoxy-d-glucose prevented the inhibitory effect of high d-glucose exposure on ghrelin release. mRNAs encoding several facilitative glucose transporters, hexokinases, the ATP-sensitive potassium channel subunit Kir6.2, and sulfonylurea type 1 receptor were expressed highly within ghrelin cells, although neither tolbutamide nor diazoxide exerted direct effects on ghrelin secretion. These findings suggest that direct exposure of ghrelin cells to low ambient d-glucose stimulates ghrelin release, whereas high d-glucose and glucose metabolism within ghrelin cells block ghrelin release. Also, low d-glucose sensitizes ghrelin cells to insulin. Various glucose transporters, channels, and enzymes that mediate glucose responsiveness in other cell types may contribute to the ghrelin cell machinery involved in regulating ghrelin secretion under these different glucose environments, although their exact roles in ghrelin release remain uncertain.
authors.affiliation: Division of Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9077, USA.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Sakata
authors.forename: Won-Mee
authors.initials: WM
authors.lastname: Park
authors.forename: Angela K
authors.initials: AK
authors.lastname: Walker
authors.forename: Paul K
authors.initials: PK
authors.lastname: Piper
authors.forename: Jen-Chieh
authors.initials: JC
authors.lastname: Chuang
authors.forename: Sherri
authors.initials: S
authors.lastname: Osborne-Lawrence
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Zigman
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D045744:Cell Line, Tumor; D019332:Endothelin-1 / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005753:Gastric Mucosa / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D054439:Ghrelin / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology*; D049452:Green Fluorescent Proteins / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009638:Norepinephrine / Q000494:pharmacology; D061251:Primary Cell Culture; D012633:Secretin / Q000494:pharmacology; D013004:Somatostatin / Q000494:pharmacology
chemical_list: D002352:Carrier Proteins; D019332:Endothelin-1; D054439:Ghrelin; D007004:Hypoglycemic Agents; D007328:Insulin; D012633:Secretin; D049452:Green Fluorescent Proteins; D013004:Somatostatin; D005947:Glucose; D009638:Norepinephrine; D004837:Epinephrine